{
    "nctId": "NCT02837783",
    "officialTitle": "A Phase 4, Single-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group, Fixed-dose Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation",
    "inclusionCriteria": "\u2022 Patient meets protocol criteria for diagnosis of IBS-C, abdominal pain, abdominal bloating and abdominal girth\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Patient has history of loose or watery stools\n* Patient has both clinically significant findings and unexplained clinically significant alarm symptoms\n* Patient has symptoms of or been diagnosed with a medical condition that may contribute to abdominal pain\n* Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments"
}